Ticker: RCEL

Company: Avita Therapeutics, Inc.

Person: David D OToole, officer

Transaction date: Aug. 12, 2025

Reporting date: Aug. 12, 2025

Average share price: 4.81

Bought 2000.0 shares for 9620.0